OBJECTIVE: To assess the outcome of a regimen of a reduced dose of mifepristone
followed by one or two doses of vaginal misoprostol as a non-surgical method for …

OBJECTIVE: The aim of the study was to assess the use, efficacy and factors influencing the
outcome of medical abortion at 9–13 weeks' gestation. METHODS: Retrospective chart …

BACKGROUND: Since 1991, mifepristone in combination with a prostaglandin analogue
has been licensed for termination of pregnancy in the UK at up to 9 weeks amenorrhoea …

BACKGROUND: Several studies have now reported the successful use of the sublingual
administration of misoprostol for medical abortion in the first trimester. The objective of this …

Objective: The purpose of this study was to assess the uptake and outcome of medical
abortion in the late first trimester of pregnancy. Study Design: We conducted a review of the …

Objective To assess women's acceptability, the efficacy and side effects of sublingual versus
vaginal administration of misoprostol in combination with mifepristone for medical abortion …

Background Repeat termination of pregnancy highlights the issues of unplanned
pregnancies and effective post-termination contraceptive practices. Objective To examine …

Context Except in the presence of significant medical indications, the legal limit for abortion
in Great Britain is 24 weeks' gestation. Nevertheless, abortion for nonmedical reasons is not …

OBJECTIVE: The purpose of this study was to compare the effectiveness of the sublingual
and vaginal administration of misoprostol for cervical priming before surgical termination of …

Objective: This study was undertaken to compare the effectiveness of mifepristone orally
administered at 24 or 48 hours before first-trimester vacuum aspiration abortion with that of …